In 2024, ForzaVitale OÜ had revenue of 858 EUR and profit of 442 EUR. Beneficial owners: Ksenia Smirnova.
| year | 2024Latest | 2023 | 2022 |
|---|---|---|---|
Revenue | 858 € +114.5% | 400 € +117.4% | 184 € -97.3% |
Profit | 442 € +531.4% | 70 € +107.6% | -924 € -1985.7% |
Assets | - | - | - |
Liabilities | - | - | - |
Equity | 3,5k € +14.4% | 3,1k € +2.3% | 3k € +110.8% |
Employees | - | - | - |
Overall rating | A87/100 |
Financial health | 95/100 |
Credit history | 70/100 |
Legal history | 100/100 |
Business activity | 85/100 |
| Overall risk | Low |
No risk flags | |
Possible tax debts | |
Positive profit | |
Regular report filing | |
| Name, surname | Birth date | Position | Representation rights | Registered | |
|---|---|---|---|---|---|
| - | Board member | - |
ForzaVitale OÜ is located at Tartu maakond, Tartu linn, Tartu linn, Riia tn 17-19, 51010.
In 2024, ForzaVitale OÜ had revenue of 858 EUR and profit of 442 EUR. Compared to previous year, revenue increased by 114.5%. View full financial report →
The beneficial owners of ForzaVitale OÜ are Ksenia Smirnova. View ownership details →
No, ForzaVitale OÜ does not have an active VAT number and is not registered as a VAT payer.
ForzaVitale OÜ was founded on November 28, 2016. The company has been operating for 10 years.
| Indicator | Value | Rank | Comparison | |
|---|---|---|---|---|
Company age | 10 years | 1237 - 1241 | 60% | |
Net revenue | 858,00 € | 2817 - 2821 | 9% | |
Profit | 442,00 € | 1457 - 1461 | 53% | |
Equity | 3511,00 € | 1777 - 1781 | 28% | |
Profitability | 51.5% | - | 90% | |
Registered capital | 2500,00 € | - | 90% |
Annual financial report for 2024.
Annual financial report for 2023.
Annual financial report for 2022.
Annual financial report for 2021.
Annual financial report for 2020.
Annual financial report for 2019.
Registered in the Estonian business register.
| Name, surname | Shares | Ownership rights | |
|---|---|---|---|
| Ksenia Smirnova | - | 100.00% |
| Name, surname | Nationality | Birth date | |
|---|---|---|---|
| Ksenia Smirnova | EE | - |